Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Rivaroxaban for thromboprophylaxis after hospitalization for medical illness
MARINER Investigators
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rivaroxaban for thromboprophylaxis after hospitalization for medical illness'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hospitalization
100%
Medical Illness
100%
Venous Thromboembolism
100%
Thromboprophylaxis
100%
Rivaroxaban
100%
Confidence Interval
42%
Placebo
42%
Hazard Ratio
42%
Major Bleeding
42%
Placebo Groups
28%
High-score
28%
Hospital Discharge
28%
Efficacy Outcomes
28%
Recurrent Venous Thromboembolism
28%
High Risk
14%
Renal Insufficiency
14%
Low Risk
14%
Non-associated
14%
Non-fatal
14%
Randomized Double-blind Trial
14%
Safety Outcomes
14%
Medical Patients
14%
Once-daily
14%
Intention-to-treat Analysis
14%
Laboratory Criteria
14%
Adjusted Dose
14%
Medically Ill Patients
14%
Medical Prevention
14%
Plasma D-dimer
14%
Extended Thromboprophylaxis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Venous Thromboembolism
100%
Rivaroxaban
100%
Placebo
55%
Bleeding
33%
Kidney Failure
11%
Dimer
11%